226 related articles for article (PubMed ID: 19880507)
1. SHIP2 (SH2 domain-containing inositol phosphatase 2) SH2 domain negatively controls SHIP2 monoubiquitination in response to epidermal growth factor.
De Schutter J; Guillabert A; Imbault V; Degraef C; Erneux C; Communi D; Pirson I
J Biol Chem; 2009 Dec; 284(52):36062-36076. PubMed ID: 19880507
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.
Chan W; Tian R; Lee YF; Sit ST; Lim L; Manser E
J Biol Chem; 2009 Mar; 284(12):8185-94. PubMed ID: 19144635
[TBL] [Abstract][Full Text] [Related]
3. Protein phosphatase 2A PR130/B''alpha1 subunit binds to the SH2 domain-containing inositol polyphosphate 5-phosphatase 2 and prevents epidermal growth factor (EGF)-induced EGF receptor degradation sustaining EGF-mediated signaling.
Zwaenepoel K; Goris J; Erneux C; Parker PJ; Janssens V
FASEB J; 2010 Feb; 24(2):538-47. PubMed ID: 19825976
[TBL] [Abstract][Full Text] [Related]
4. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
5. The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2.
Vandenbroere I; Paternotte N; Dumont JE; Erneux C; Pirson I
Biochem Biophys Res Commun; 2003 Jan; 300(2):494-500. PubMed ID: 12504111
[TBL] [Abstract][Full Text] [Related]
6. HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.
Lin Q; Wang J; Childress C; Sudol M; Carey DJ; Yang W
Mol Cell Biol; 2010 Mar; 30(6):1541-54. PubMed ID: 20086093
[TBL] [Abstract][Full Text] [Related]
7. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
Artemenko Y; Gagnon A; Sorisky A
J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
[TBL] [Abstract][Full Text] [Related]
8. SHIP2 associates with intersectin and recruits it to the plasma membrane in response to EGF.
Xie J; Vandenbroere I; Pirson I
FEBS Lett; 2008 Sep; 582(20):3011-7. PubMed ID: 18692052
[TBL] [Abstract][Full Text] [Related]
9. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.
Pesesse X; Dewaste V; De Smedt F; Laffargue M; Giuriato S; Moreau C; Payrastre B; Erneux C
J Biol Chem; 2001 Jul; 276(30):28348-55. PubMed ID: 11349134
[TBL] [Abstract][Full Text] [Related]
10. Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
Zeng F; Xu J; Harris RC
FASEB J; 2009 Jun; 23(6):1935-45. PubMed ID: 19193720
[TBL] [Abstract][Full Text] [Related]
11. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.
Prasad NK; Werner ME; Decker SJ
Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129
[TBL] [Abstract][Full Text] [Related]
12. The SH2 domains of inositol polyphosphate 5-phosphatases SHIP1 and SHIP2 have similar ligand specificity but different binding kinetics.
Zhang Y; Wavreille AS; Kunys AR; Pei D
Biochemistry; 2009 Nov; 48(46):11075-83. PubMed ID: 19839650
[TBL] [Abstract][Full Text] [Related]
13. Monoubiquitination of RPN10 regulates substrate recruitment to the proteasome.
Isasa M; Katz EJ; Kim W; Yugo V; González S; Kirkpatrick DS; Thomson TM; Finley D; Gygi SP; Crosas B
Mol Cell; 2010 Jun; 38(5):733-45. PubMed ID: 20542005
[TBL] [Abstract][Full Text] [Related]
14. SHIP2 multiple functions: a balance between a negative control of PtdIns(3,4,5)P₃ level, a positive control of PtdIns(3,4)P₂ production, and intrinsic docking properties.
Erneux C; Edimo WE; Deneubourg L; Pirson I
J Cell Biochem; 2011 Sep; 112(9):2203-9. PubMed ID: 21503961
[TBL] [Abstract][Full Text] [Related]
15. SH2-containing 5'-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent down-regulation of the epidermal growth factor receptor.
Prasad NK; Decker SJ
J Biol Chem; 2005 Apr; 280(13):13129-36. PubMed ID: 15668240
[TBL] [Abstract][Full Text] [Related]
16. SHIP2 interaction with the cytoskeletal protein Vinexin.
Paternotte N; Zhang J; Vandenbroere I; Backers K; Blero D; Kioka N; Vanderwinden JM; Pirson I; Erneux C
FEBS J; 2005 Dec; 272(23):6052-66. PubMed ID: 16302969
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of SIRT1 by 17β-estradiol depends on ubiquitin-proteasome degradation of PPAR-γ mediated by NEDD4-1.
Han L; Wang P; Zhao G; Wang H; Wang M; Chen J; Tong T
Protein Cell; 2013 Apr; 4(4):310-21. PubMed ID: 23549616
[TBL] [Abstract][Full Text] [Related]
18. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
19. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
20. The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity.
Pesesse X; Moreau C; Drayer AL; Woscholski R; Parker P; Erneux C
FEBS Lett; 1998 Oct; 437(3):301-3. PubMed ID: 9824312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
